hsa-mir-1184: hsa-mir-1184 is a microRNA implicated in various biological processes and diseases. It was identified as one of the microRNAs that may interact with GAPLINC, a long non-coding RNA, and was selected as a superior candidate for further study [PMC5902673]. The expression of hsa-mir-1184 was found to significantly increase in prostatic cancer, suggesting its potential role in cancer biology [PMC5452331]. While hsa-mir-1184 is downregulated in degenerative discs, its exact role in the regulation of genes within the PI3K/AKT signaling pathway, which is associated with these conditions, is not explicitly stated [PMC6896343]. In the context of sepsis in children, hsa-mir-1184 has deregulated flow and has been identified as a potential therapeutic target due to its effects on inflammatory responses and apoptosis [PMC9259025]. Additionally, hsa-mir-1184 has been associated with rheumatoid arthritis (RA) development and may serve as a diagnostic biomarker for distinguishing RA from healthy samples [PMC8889404]. It also shares target genes with hsa-miR-24, suggesting a role in the development of pancreatic cancer (PC) and potential as a therapeutic target [PMC5228663]. Furthermore, it was found that changes in circFLNA expression had no effect on hsa-mir-1184 expression levels, indicating specific regulatory mechanisms [PMC10023616].